Evidence map›Paper›PMID 26024121›Full record

ArticleInvestigative ophthalmology & visual science2015

Cdc42 and sec10 Are Required for Normal Retinal Development in Zebrafish.

Soo Young Choi, Jeong-In Baek, Xiaofeng Zuo, Seok-Hyung Kim, Joshua L Dunaief, Joshua H Lipschutz

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.5field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. The exocyst in ciliogenesis.Renal failure · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Soo Young ChoiDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Jeong-In BaekDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Xiaofeng ZuoDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Seok-Hyung KimDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States.
Joshua L DunaiefF.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Joshua H LipschutzDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States 3Department of Medicine, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, United States.
Medical University of South Carolina · USPenn Presbyterian Medical Center · USRalph H. Johnson VA Medical Center · US

Funding

UAB Recessive PKD Research and Translational Core CenterP30DK074038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 2005 to 2019
$16.6M
Retinal Iron Transport in Health and DiseaseR01EY015240 · NEI · UNIVERSITY OF PENNSYLVANIA · PI JOSHUA L DUNAIEF · 2004 to 2026
$10.4M
The Exocyst in Synthesis, Cystogenesis and TubulogenesisR01DK069909 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LIPSCHUTZ, JOSHUA H · 2005 to 2009
$1.3M
Gene Expression Changes in Early 3D Renal TubulogenesisR21DK070980 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LIPSCHUTZ, JOSHUA H · 2006 to 2007
$310k
The exocyst in ciliogenesis and cystogenesisI01BX000820 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI JOSHUA H LIPSCHUTZ · 2011 to 2026
–
BLRD VA I01 BX000820NEI NIH HHS R01 EY015240NIDDK NIH HHS DK069909NIDDK NIH HHS DK070980NIDDK NIH HHS P30 DK074038NIDDK NIH HHS R01 DK069909NIDDK NIH HHS R21 DK070980
6 · The paper itself

Abstract

purposeTo characterize the function and mechanisms of cdc42 and sec10 in eye development in zebrafish.

methodsKnockdown of zebrafish cdc42 and sec10 was carried out using antisense morpholino injection. The phenotype of morphants was characterized by histology, immunohistology, and transmission electron microscopy (TEM). To investigate a synergistic genetic interaction between cdc42 and sec10, we titrated suboptimal doses of cdc42 and sec10 morpholinos, and coinjected both morpholinos. To study trafficking, a melanosome transport assay was performed using epinephrine.

resultsCdc42 and sec10 knockdown in zebrafish resulted in both abnormal eye development and increased retinal cell death. Cdc42 morphants had a relatively normal retinal structure, aside from the absence of most connecting cilia and outer segments, whereas in sec10 morphants, much of the outer nuclear layer, which is composed of the photoreceptor nuclei, was missing and RPE cell thickness was markedly irregular. Knockdown of cdc42 and sec10 also resulted in an intracellular transport defect affecting retrograde melanosome transport. Furthermore, there was a synergistic genetic interaction between zebrafish cdc42 and sec10, suggesting that cdc42 and sec10 act in the same pathway in retinal development.

conclusionsWe propose a model whereby sec10 and cdc42 play a central role in development of the outer segment of the retinal photoreceptor cell by trafficking proteins necessary for ciliogenesis.

Indexed as

Animalscdc42 GTP-Binding ProteinEye ProteinsGene SilencingOrgan SizeRetinaRetinal DegenerationVesicular Transport ProteinsZebrafishZebrafish Proteinscdc42 GTP-Binding ProteinEye ProteinsVesicular Transport ProteinsZebrafish Proteins

Identifiers

PMID26024121
PMCPMC4453986
OpenAlexW2399789234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.